MDXH logo

MDxHealth SA American Depositary Shares


MDXH: MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.


Show MDXH Financials

Consumer Interest
SEC Filings

Recent trades of MDXH by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by MDXH's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Method for predicting and treating clinically significant prostate cancer Sep. 26, 2023
  • Patent Title: Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samples Nov. 06, 2018
  • Patent Title: Method for determining the methylation status of the promoter region of the twist1 gene in genomic dna from bladder cells Oct. 30, 2018
  • Patent Title: Methylation detection of the mgmt promoter Aug. 21, 2018
  • Patent Title: Methods of detecting mutations in braf and epigenetic changes Mar. 28, 2017
  • Patent Title: Methylation of the gata4 gene in urine samples as a marker for bladder cancer detection Jul. 12, 2016
  • Patent Title: Methods for determining methylation of the twist1 gene for bladder cancer detection Apr. 26, 2016
  • Patent Title: Methylation detection of mgmt Jun. 09, 2015
  • Patent Title: Methods for detecting epigenetic modifications Mar. 03, 2015
  • Patent Title: Detection of mage-a expression Jul. 09, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of MDXH in WallStreetBets Daily Discussion


Recent insights relating to MDXH

CNBC Recommendations

Recent picks made for MDXH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDXH

Corporate Flights

Flights by private jets registered to MDXH